Purus Wealth Management LLC Reduces Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Purus Wealth Management LLC decreased its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 75.7% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 21,119 shares of the company’s stock after selling 65,801 shares during the period. Purus Wealth Management LLC’s holdings in ARK Genomic Revolution ETF were worth $497,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Wealthcare Advisory Partners LLC increased its holdings in shares of ARK Genomic Revolution ETF by 2.8% in the 4th quarter. Wealthcare Advisory Partners LLC now owns 15,903 shares of the company’s stock valued at $374,000 after acquiring an additional 435 shares during the period. Crescent Grove Advisors LLC lifted its stake in shares of ARK Genomic Revolution ETF by 1.6% during the 3rd quarter. Crescent Grove Advisors LLC now owns 28,914 shares of the company’s stock worth $740,000 after purchasing an additional 460 shares during the last quarter. Bridges Investment Management Inc. boosted its position in ARK Genomic Revolution ETF by 3.8% during the second quarter. Bridges Investment Management Inc. now owns 14,121 shares of the company’s stock valued at $332,000 after purchasing an additional 517 shares in the last quarter. National Bank of Canada FI grew its stake in ARK Genomic Revolution ETF by 28.4% in the third quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after purchasing an additional 920 shares during the last quarter. Finally, Brown Miller Wealth Management LLC raised its holdings in ARK Genomic Revolution ETF by 5.5% in the third quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock worth $460,000 after purchasing an additional 933 shares in the last quarter.

ARK Genomic Revolution ETF Stock Up 2.3 %

ARKG stock opened at $24.14 on Monday. The firm’s 50 day moving average price is $24.77 and its 200-day moving average price is $25.05.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.